Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127678621 | 12767862 | 1 | I | 20160916 | 20160921 | 20160921 | EXP | TR-MYLANLABS-2016M1040273 | MYLAN | ALTINYAZAR V, KIYLIOGLU N. INSOMNIA AND DEMENTIA: IS AGOMELATINE TREATMENT HELPFUL? CASE REPORT AND REVIEW OF THE LITERATURE. THERAP-ADV-PSYCHOPHARMACOL 2016;6(4):263-268. | 0.00 | Y | 0.00000 | 20160921 | MD | TR | TR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127678621 | 12767862 | 1 | PS | LORAZEPAM. | LORAZEPAM | 1 | Unknown | 1.25 MG/DAY | Y | 77657 | |||||||||
| 127678621 | 12767862 | 2 | C | MEMANTINE. | MEMANTINE | 1 | Unknown | 20 MG/DAY | D | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127678621 | 12767862 | 1 | Insomnia |
| 127678621 | 12767862 | 2 | Dementia Alzheimer's type |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127678621 | 12767862 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127678621 | 12767862 | Cognitive disorder | |
| 127678621 | 12767862 | Impaired self-care | |
| 127678621 | 12767862 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |